Many people using GLP-1 medications such as Ozempic and Mounjaro for weight loss report an unexpected challenge known as a “plateau,” where progress slows or temporarily stops. These drugs were originally developed to help manage type 2 diabetes by regulating blood sugar, but they have become widely used for weight management due to their ability to reduce appetite and calorie intake. However, experts say the body naturally adapts over time. According to Dr. Grace Lim, a board-certified obesity medicine specialist, most patients eventually reach a point where weight loss slows because the body becomes more efficient at conserving energy. At this stage, some individuals become frustrated and may request higher doses or even take additional injections, which doctors strongly discourage due to safety concerns.

Medical professionals warn that increasing dosage without supervision can lead to serious side effects such as nausea, vomiting, abdominal pain, dizziness, dehydration, and dangerously low blood sugar levels. In some cases, patients have required hospital treatment after misusing the medication. Experts explain that plateaus often occur when the body reaches a healthier weight and begins resisting further fat loss by slowing metabolism and increasing hunger signals. Dr. Jason Ng describes it as a balance point where energy intake equals energy expenditure. To overcome this safely, specialists recommend lifestyle adjustments rather than medication changes, including strength training to preserve muscle mass, increasing daily activity, and consuming adequate protein. Good sleep, hydration, and stress management also play important roles in supporting metabolism. Doctors emphasize that while GLP-1 drugs can be effective tools, long-term success depends on combining them with sustainable healthy habits and professional medical guidance.